bpc 157 level up What is BPC-157? BPC-157 – Research Peptide |

PMID 2137911 Subcutaneous injection-site pharmacokinetics FDA review

Technical Specifications Compound: BPC-157 (Synthetic Pentadecapeptide) Format: Lyophilized peptide powder Strength: 10 mg per vial Purity: 9899% (COA included) Appearance: White lyophilized powder Category: Research peptide reagent Intended Use This product is intended strictly for: Laboratory experimentation In-vitro scientific research Biochemical and molecular studies Non-human preclinical model development Institutional or academic research programs Not intended for: Human or animal consumption Injection, ingestion, inhalation, or topical use Medical, therapeutic, diagnostic, or cosmetic purposes This compound is not approved by Health Canada, FDA, or any regulatory authority for clinical use

BPC-157 at 250 mcg once or twice daily provides ongoing tissue support without aggressive dosing

In both mice and rhesus macaques, a two-dose intramuscular immunization regimen resulted in durable, robust, and broad neutralization against all SARS-CoV-2 variants tested, including the Omicron subvariants BA.4/539 and BQ.140

Lecithin, phosphatidylcholine and choline - Learn more about the potential link between them and cardiovascular disease

In each case, inform patients to resume their regular once weekly dosing schedule [see Dosage and Administration (2.3)]